National Health Investors
235 hedge funds and large institutions have $2.29B invested in National Health Investors in 2018 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 90 increasing their positions, 63 reducing their positions, and 24 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 63
42% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 24
3% more funds holding
Funds holding: 228 → 235 (+7)
1.67% more ownership
Funds ownership: 70.16% → 71.84% (+1.7%)
2% more capital invested
Capital invested by funds: $2.24B → $2.29B (+$55.9M)
8% less call options, than puts
Call options by funds: $18.5M | Put options by funds: $20.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIMS
Lasalle Investment Management Securities
Baltimore,
Maryland
|
+$57M |
| 2 |
Renaissance Technologies
New York
|
+$24.1M |
| 3 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
+$10.3M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$7.36M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$5.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$48M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$13M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$6.87M |
| 4 |
Charles Schwab
San Francisco,
California
|
-$5.14M |
| 5 |
Goldman Sachs
New York
|
-$4.81M |
NHI Hedge Fund Activity: Q4 2018 in Review
235 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q4 2018, worth a combined $2.29B — up 2.5% from $2.24B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new NHI positions and 24 closed out — a net gain of 10 holders — while 90 added to existing stakes and 63 trimmed.
The largest buyer was Lasalle Investment Management Securities, opening a new position worth an estimated $57M. The largest seller was JP Morgan Chase, cutting an estimated $48M.
- 235 institutional investors held National Health Investors (NHI) as of Q4 2018, up from 228 in Q3 2018.
- Funds reported $2.29B of National Health Investors stock for Q4 2018, up 2.5% quarter-over-quarter.
- 34 funds opened new National Health Investors positions in Q4 2018 and 24 closed out, a net change of +10 holders.
- The largest National Health Investors buyer in Q4 2018 was Lasalle Investment Management Securities, an estimated $57M added.
- The largest National Health Investors seller in Q4 2018 was JP Morgan Chase, an estimated $48M sold.
Based on aggregated 13F filings for Q4 2018.